21 results
424B4
RNAZ
TransCode Therapeutics Inc
19 Jan 24
Prospectus supplement with pricing info
9:57pm
in clinical trials may not be indicative of results obtained when such trials are completed. There is typically an extremely high rate of attrition from
DRS
j7l0vq5
29 Jul 22
Draft registration statement
12:00am
10-K
ix5p0
31 Mar 22
Annual report
11:19am
10-Q
acf88wana1omol6x
23 Aug 21
Quarterly report
4:53pm
424B4
k6ht87wtkh
9 Jul 21
Prospectus supplement with pricing info
5:22pm
S-1
cqb btuno21gyazuz4v
26 Feb 21
IPO registration
4:06pm
DRS/A
lsrufxt
27 Jan 21
Draft registration statement (amended)
12:00am